16/06/2026
GLP-1 drugs do not appear to harm male fertility and may even improve it🧐
Glucagon-like peptide-like 1 (GLP-1) receptor agonists, widely used to treat obesity and type 2 diabetes, are attracting growing interest beyond their metabolic effects.
Drugs such as semaglutide, liraglutide or dulaglutide have revolutionized the treatment of obesity, but one question continues to generate debate among patients and specialists: do they affect male fertility?
More information in this link and i the section NEWS of our website 🤓
https://nutrigenomicsinstitute.com/nutrigenomics-news/glp-1-drugs-do-not-appear-to-harm-male-fertility-and-may-even-improve-it/